Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

T0901317 inhibits cisplatin-induced apoptosis in ovarian cancer cells [corrected].

Miller DH, Fischer AK, Chu KF, Burr R, Hillenmeyer S, Brard L, Brodsky AS.

Int J Gynecol Cancer. 2011 Nov;21(8):1350-6. doi: 10.1097/IGC.0b013e318228f558. Erratum in: Int J Gynecol Cancer. 2011 Dec;21(9):1711.

2.
3.

Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein.

Scoles DR, Xu X, Wang H, Tran H, Taylor-Harding B, Li A, Karlan BY.

Gynecol Oncol. 2010 Jan;116(1):109-16. doi: 10.1016/j.ygyno.2009.09.034.

PMID:
19854496
4.
5.

HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.

Selvendiran K, Ahmed S, Dayton A, Kuppusamy ML, Rivera BK, Kálai T, Hideg K, Kuppusamy P.

Cancer Biol Ther. 2011 Nov 1;12(9):837-45. doi: 10.4161/cbt.12.9.17713.

PMID:
21885917
6.
7.

Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.

Chen Y, Duan Y, Yang X, Sun L, Liu M, Wang Q, Ma X, Zhang W, Li X, Hu W, Miao RQ, Xiang R, Hajjar DP, Han J.

Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):948-59. doi: 10.1161/ATVBAHA.114.305116.

8.

LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects.

Spillmann F, Van Linthout S, Miteva K, Lorenz M, Stangl V, Schultheiss HP, Tschöpe C.

Atherosclerosis. 2014 Jan;232(1):1-9. doi: 10.1016/j.atherosclerosis.2013.10.001.

PMID:
24401210
9.

Lycopene and the LXRα agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARγ-LXRα-ABCA1 pathway.

Yang CM, Lu YL, Chen HY, Hu ML.

J Nutr Biochem. 2012 Sep;23(9):1155-62. doi: 10.1016/j.jnutbio.2011.06.009.

PMID:
22137263
10.

Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer.

Ehlén A, Brennan DJ, Nodin B, O'Connor DP, Eberhard J, Alvarado-Kristensson M, Jeffrey IB, Manjer J, Brändstedt J, Uhlén M, Pontén F, Jirström K.

J Transl Med. 2010 Aug 20;8:78. doi: 10.1186/1479-5876-8-78.

11.

Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells.

Tsui KH, Chung LC, Feng TH, Lee TY, Chang PL, Chen WT, Juang HH.

Prostate. 2015 May;75(6):603-15. doi: 10.1002/pros.22944.

PMID:
25560459
12.

Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells.

Fukuchi J, Kokontis JM, Hiipakka RA, Chuu CP, Liao S.

Cancer Res. 2004 Nov 1;64(21):7686-9.

13.

Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.

Zhao H, Wei W, Sun Y, Gao J, Wang Q, Zheng J.

DNA Cell Biol. 2015 Jan;34(1):55-62. doi: 10.1089/dna.2014.2626.

PMID:
25211326
14.

[Effect of liver X receptors agonists T0901317 on expression of FAT/CD36 gene mRNA in adult human skeletal muscle cell].

Zeng R, Sa YL, Yan XM.

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2009 Aug;25(3):428-32. Chinese.

PMID:
21155254
15.

Regulation of bile acid, cholesterol, and fatty acid synthesis in chicken primary hepatocytes by different concentrations of T0901317, an agonist of liver X receptors.

Sato K, Kamada T.

Comp Biochem Physiol A Mol Integr Physiol. 2011 Feb;158(2):201-6. doi: 10.1016/j.cbpa.2010.10.028.

PMID:
21056113
16.
17.

[Liver X receptor agonist T0901317 inhibits TGF-β1-induced α-SMA expression in normal human lung fibroblasts].

Ren DQ, Liu M, Guo YZ, Ma R, Zhong NS.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 May;31(5):744-8. Chinese.

18.

[Effect of liver X receptor agonist T0901317 on endothelin-1 induced murine HL-1 cardiomyocytes hypertrophy].

Li J, Deng C, Gu WJ, Nie S, Peng DQ, Zhao SP.

Zhonghua Xin Xue Guan Bing Za Zhi. 2012 Feb;40(2):161-5. Chinese.

PMID:
22490719
19.

Upregulation of Fas in epithelial ovarian cancer reverses the development of resistance to cisplatin.

Yang F, Long W, Xuechuan H, Xueqin L, Hongyun M, Yonghui D.

BMB Rep. 2015 Jan;48(1):30-5.

20.

XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.

Ma JJ, Chen BL, Xin XY.

Eur J Obstet Gynecol Reprod Biol. 2009 Oct;146(2):222-6. doi: 10.1016/j.ejogrb.2009.06.011.

PMID:
19758744
Items per page

Supplemental Content

Support Center